CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-07 | 2024-05-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.11 | -15.5K | 137.1K | -10% | -$1.01M |
| 2024-04-25 | 2024-04-25 | CYTK | HENDERSON JOHN T | Dir | S - Sale | $64.54 | -10.6K | 32.1K | -25% | -$681.7K | |
| 2024-04-15 | 2024-04-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | G - Gift | $0.00 | -150 | 138.4K | -0.1% | $0 | |
| D | 2024-04-09 | 2024-04-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.67 | +28.6K | 171.2K | +20% | +$190.8K |
| DM | 2024-04-09 | 2024-04-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $74.31 | -32.6K | 142.6K | -19% | -$2.42M |
| D | 2024-03-18 | 2024-03-14 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +61.5K | 461.2K | +15% | $0 |
| D | 2024-03-18 | 2024-03-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +21.3K | 142.6K | +18% | $0 |
| D | 2024-03-18 | 2024-03-14 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +16.9K | 63.9K | +36% | $0 |
| D | 2024-03-18 | 2024-03-14 | CYTK | Wong Robert | VP, CAO | A - Grant | $0.00 | +4,079 | 29.7K | +16% | $0 |
| M | 2024-03-07 | 2024-03-04+ | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $67.12 | -7,305 | 52.0K | -12% | -$490.3K |
| M | 2024-03-07 | 2024-03-04+ | CYTK | Wong Robert | VP, CAO | F - Tax | $67.42 | -2,640 | 25.6K | -9% | -$178.0K |
| M | 2024-03-07 | 2024-03-04+ | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $67.36 | -42.1K | 399.7K | -10% | -$2.83M |
| M | 2024-03-07 | 2024-03-04+ | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $67.31 | -17.7K | 121.2K | -13% | -$1.19M |
| D | 2024-03-05 | 2024-03-05 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.67 | +28.6K | 167.6K | +21% | +$190.8K |
| DM | 2024-03-05 | 2024-03-05 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $67.56 | -32.6K | 139.0K | -19% | -$2.20M |
| D | 2024-02-14 | 2024-02-14 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $76.48 | -5,000 | 42.6K | -10% | -$382.4K |
| D | 2024-02-14 | 2024-02-14 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $4.44 | +5,000 | 47.6K | +12% | +$22.2K |
| D | 2024-02-13 | 2024-02-13 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $76.85 | -12.5K | 441.8K | -3% | -$960.6K |
| D | 2024-02-13 | 2024-02-13 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| DM | 2024-02-06 | 2024-02-06 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $79.30 | -32.6K | 143.0K | -19% | -$2.59M |
| D | 2024-02-06 | 2024-02-06 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.67 | +28.6K | 175.6K | +19% | +$190.8K |
| D | 2024-02-02 | 2024-01-31 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| D | 2024-02-02 | 2024-01-31 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $79.57 | -12.5K | 441.8K | -3% | -$994.6K |
| D | 2024-01-22 | 2024-01-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| D | 2024-01-22 | 2024-01-19 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $81.42 | -12.5K | 441.8K | -3% | -$1.02M |
| D | 2024-01-12 | 2024-01-12 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $4.44 | +5,000 | 47.6K | +12% | +$22.2K |
| D | 2024-01-12 | 2024-01-12 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $85.14 | -5,000 | 42.6K | -10% | -$425.7K |
| DM | 2024-01-04 | 2024-01-04 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $86.98 | -15.7K | 147.0K | -10% | -$1.36M |
| D | 2024-01-04 | 2024-01-04 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +11.7K | 162.7K | +8% | +$93.0K |
| 2024-01-03 | 2024-01-02 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $84.12 | +148 | 18.8K | +0.8% | +$12.4K | |
| 2024-01-03 | 2024-01-02 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $84.12 | +74 | 18.7K | +0.4% | +$6,225 | |
| 2024-01-03 | 2024-01-02 | CYTK | Wysenski Nancy | Dir | A - Grant | $84.12 | +74 | 17.2K | +0.4% | +$6,225 | |
| 2024-01-03 | 2024-01-02 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $84.12 | +148 | 11.5K | +1% | +$12.4K | |
| 2024-01-03 | 2024-01-02 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $84.12 | +252 | 42.6K | +0.6% | +$21.2K | |
| 2024-01-03 | 2024-01-02 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $84.12 | +148 | 19.3K | +0.8% | +$12.4K | |
| D | 2024-01-02 | 2024-01-02 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $85.08 | -12.5K | 441.8K | -3% | -$1.06M |
| D | 2024-01-02 | 2024-01-02 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| DM | 2023-12-27 | 2023-12-27 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $73.60 | -10.0K | 18.7K | -35% | -$736.0K |
| DM | 2023-12-27 | 2023-12-27 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $4.44 | +10.0K | 23.7K | +73% | +$44.4K |
| D | 2023-12-19 | 2023-12-18 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| D | 2023-12-19 | 2023-12-18 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $36.95 | -12.5K | 441.8K | -3% | -$461.9K |
| D | 2023-12-19 | 2023-12-18 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $6.72 | +13.0K | 44.8K | +41% | +$87.5K |
| D | 2023-12-19 | 2023-12-18 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $36.34 | -2,458 | 42.4K | -5% | -$89.3K |
| D | 2023-12-01 | 2023-11-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $32.99 | -12.5K | 441.4K | -3% | -$412.4K |
| D | 2023-12-01 | 2023-11-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| D | 2023-11-15 | 2023-11-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $34.57 | -12.5K | 441.4K | -3% | -$432.1K |
| D | 2023-11-15 | 2023-11-15 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| 2023-11-09 | 2023-11-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $35.40 | -2,500 | 150.7K | -2% | -$88.5K | |
| D | 2023-10-30 | 2023-10-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| D | 2023-10-30 | 2023-10-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $32.17 | -12.5K | 441.4K | -3% | -$402.1K |
| D | 2023-10-16 | 2023-10-16 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| D | 2023-10-16 | 2023-10-16 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $33.70 | -12.5K | 441.4K | -3% | -$421.3K |
| 2023-10-12 | 2023-10-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $35.89 | -2,500 | 153.2K | -2% | -$89.7K | |
| D | 2023-10-06 | 2023-10-06 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $30.00 | -12.5K | 441.4K | -3% | -$375.0K |
| D | 2023-10-06 | 2023-10-06 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| 2023-10-03 | 2023-10-02 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $27.88 | +448 | 18.7K | +2% | +$12.5K | |
| 2023-10-03 | 2023-10-02 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $27.88 | +448 | 18.7K | +2% | +$12.5K | |
| 2023-10-03 | 2023-10-02 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $27.88 | +762 | 31.8K | +2% | +$21.2K | |
| 2023-10-03 | 2023-10-02 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $27.88 | +448 | 11.4K | +4% | +$12.5K | |
| 2023-10-03 | 2023-10-02 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $27.88 | +448 | 19.2K | +2% | +$12.5K | |
| 2023-10-03 | 2023-10-02 | CYTK | Wysenski Nancy | Dir | A - Grant | $27.88 | +224 | 17.1K | +1% | +$6,245 | |
| 2023-09-14 | 2023-09-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $34.86 | -2,500 | 155.7K | -2% | -$87.2K | |
| D | 2023-09-13 | 2023-09-13 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $34.90 | -12.5K | 441.4K | -3% | -$436.2K |
| D | 2023-09-13 | 2023-09-13 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 453.9K | +3% | +$83.4K |
| DM | 2023-08-28 | 2023-08-25 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.70 | +12.5K | 443.9K | +3% | +$96.3K |
| D | 2023-08-28 | 2023-08-25 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $33.99 | -12.5K | 441.4K | -3% | -$424.9K |
| D | 2023-08-21 | 2023-08-21 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $32.02 | -6,020 | 18.2K | -25% | -$192.8K |
| D | 2023-08-21 | 2023-08-21 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.72 | +6,020 | 24.2K | +33% | +$40.5K |
| DM | 2023-08-11 | 2022-12-21+ | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.50 | -22.5K | 406.4K | -5% | -$843.8K |
| DM | 2023-08-11 | 2022-12-21+ | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.59 | +22.5K | 416.4K | +6% | +$215.8K |
| 2023-08-10 | 2023-08-10 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $31.70 | -2,500 | 158.2K | -2% | -$79.2K | |
| DM | 2023-08-01 | 2023-08-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $32.63 | -12.5K | 441.4K | -3% | -$407.9K |
| DM | 2023-08-01 | 2023-08-01 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 443.2K | +3% | +$120.6K |
| 2023-07-13 | 2023-07-13 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $35.37 | -2,500 | 160.7K | -2% | -$88.4K | |
| D | 2023-07-13 | 2023-07-13 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $35.28 | -12.5K | 441.4K | -3% | -$441.0K |
| D | 2023-07-13 | 2023-07-13 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.9K | +3% | +$120.6K |
| 2023-07-07 | 2023-07-07 | CYTK | Bhanji Muna | Dir | S - Sale | $34.12 | -2,000 | 14.0K | -12% | -$68.2K | |
| 2023-07-05 | 2023-07-03 | CYTK | Wysenski Nancy | Dir | A - Grant | $33.36 | +187 | 16.9K | +1% | +$6,238 | |
| 2023-07-05 | 2023-07-03 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $33.36 | +636 | 31.1K | +2% | +$21.2K | |
| 2023-07-05 | 2023-07-03 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $33.36 | +374 | 10.9K | +4% | +$12.5K | |
| 2023-07-05 | 2023-07-03 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $33.36 | +374 | 18.7K | +2% | +$12.5K | |
| D | 2023-07-05 | 2023-07-03 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.9K | +3% | +$120.6K |
| D | 2023-07-05 | 2023-07-03 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $32.60 | -12.5K | 441.4K | -3% | -$407.5K |
| 2023-07-05 | 2023-07-03 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $33.36 | +374 | 18.2K | +2% | +$12.5K | |
| 2023-07-05 | 2023-07-03 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $33.36 | +374 | 18.2K | +2% | +$12.5K | |
| D | 2023-06-12 | 2023-06-12 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.06 | -12.5K | 441.4K | -3% | -$463.2K |
| D | 2023-06-12 | 2023-06-12 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.9K | +3% | +$120.6K |
| 2023-06-08 | 2023-06-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $38.07 | -2,500 | 163.2K | -2% | -$95.2K | |
| D | 2023-06-01 | 2023-05-31 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +12.5K | 453.6K | +3% | +$120.6K |
| D | 2023-06-01 | 2023-05-31 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.67 | -12.5K | 441.1K | -3% | -$470.9K |
| D | 2023-05-18 | 2023-05-10 | CYTK | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,000 | 15.0K | +50% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | Bhanji Muna | Dir | A - Grant | $0.00 | +5,000 | 16.0K | +45% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $0.00 | +5,000 | 10.6K | +90% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +5,000 | 18.3K | +37% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $0.00 | +5,000 | 30.4K | +20% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | COSTA SANTO J | Dir | A - Grant | $0.00 | +5,000 | 15.0K | +50% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $0.00 | +5,000 | 17.8K | +39% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +5,000 | 16.7K | +43% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $0.00 | +5,000 | 17.8K | +39% | $0 |
| D | 2023-05-16 | 2023-05-16 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.41 | -12.5K | 441.1K | -3% | -$467.6K |
Purchase Sale Sale after option exercise All abbreviations